Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Intercept Announces Positive Pivotal Phase 3 POISE Trial Results
Yahoo/Globe Newswire
Sunday, March 16, 2014 - 11:46am
tags:
Intercept Pharma, obeticholic acid, primary biliary cirrhosis
Investors Don't Celebrate Celebrex Decision Favoring Cheap Generics
Motley Fool
Sunday, March 16, 2014 - 11:45am
tags:
Pfizer, Celebrex, patents, generics
Is Pfizer a Buy?
Wall St Cheat Sheet
Sunday, March 16, 2014 - 11:43am
tags:
Pfizer
Will Obamacare Harm These Biotech Stocks?
Motley Fool
Saturday, March 15, 2014 - 12:52pm
tags:
Celgene
Orchid Pharma gets nod for CDR
Business Standard, India
Saturday, March 15, 2014 - 10:39am
tags:
Orchid Pharma
Exuberant, Yes: Michael King on How the Oncology Drug Development Machine Builds Biotech Wealth
Jutia Group
Saturday, March 15, 2014 - 10:37am
tags:
Can AbbVie Continue Its Bull Run?
Motley Fool
Saturday, March 15, 2014 - 10:13am
tags:
AbbVie
J&J Lawsuit Sheds Light on Link Between Doctors and Device Makers
Wall St Cheat Sheet
Saturday, March 15, 2014 - 10:11am
tags:
JNJ, lawsuits, devices
FDA Grants New Indication For Pfizer/Bristol Anticoagulant
Forbes
Saturday, March 15, 2014 - 10:10am
tags:
Pfizer, DVT, Bristol-Myers Squibb, Apixaban, anticoagulants, Eliquis
Health-Care Stocks: Growing Like Gangbusters
Motley Fool
Saturday, March 15, 2014 - 10:06am
tags:
Regeneron, Sanofi, Gilead Sciences, Celgene, Allergan
Harwood Feffer LLP Announces Investigation of CytRx Corporation
Yahoo/PR NewsWire
Saturday, March 15, 2014 - 10:04am
tags:
CytRx
Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study
Yahoo/The Fly on the Wall
Saturday, March 15, 2014 - 10:03am
tags:
Amgen, Talimogene Laherparepvec, melanoma
The Baupost Group ups its stake in Idenix Pharmaceuticals
Yahoo/Market Realist
Saturday, March 15, 2014 - 10:01am
tags:
Idenix
Why Teva May Be Back From the Dead
Wall St 24/7
Friday, March 14, 2014 - 11:17am
tags:
Teva Pharmaceuticals
AVEO Q4 Loss Narrower than Expected
Yahoo/Zacks.com
Friday, March 14, 2014 - 11:17am
tags:
Aveo Pharmaceuticals, earnings
Gilead's hot-selling Sovaldi draws more patent attacks
Fierce Pharma
Friday, March 14, 2014 - 11:15am
tags:
Sovaldi, Idenix, Merck, Roche, hepatitis C, patents, Gilead Sciences
Narrower-than-Expected Q4 Loss at Repros
Yahoo/Zacks.com
Friday, March 14, 2014 - 11:13am
tags:
Repros Therapeutics, earnings
MannKind: The Gambler's Creed - Let It Ride
Seeking Alpha
Friday, March 14, 2014 - 10:54am
tags:
MannKind, Afrezza, diabetes
Ten Top Biotech Merger and Partnership Candidates
Wall St 24/7
Friday, March 14, 2014 - 10:53am
tags:
M&A, biotech, Alkermes, Akorn, Auxilium, Cubist Pharmaceuticals, Hospira, Jazz Pharmaceuticals, Medivation, NPS Pharmaceuticals, Salix, United Therapeutics
Ranbaxy served with Supreme Court notice for allegedly supplying substandard, adulterated drugs in India
First Word Pharma
Friday, March 14, 2014 - 10:23am
tags:
Ranbaxy, India, Supreme Court

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.